Patients’ preferences and willingness-to-pay for postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer treatments after failure of standard treatments
Crossref DOI link: https://doi.org/10.1186/s40064-015-1482-9
Published Online: 2015-11-05
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ngorsuraches, Surachat
Thongkeaw, Klangjai
License valid from 2015-11-05